Ma Christopher, Chen Yixin, Wilkins Dawn, Chen Xiang, Zhang Jinghui
BMC Genomics. 2015;16 Suppl 9(Suppl 9):S3. doi: 10.1186/1471-2164-16-S9-S3. Epub 2015 Aug 17.
Cancer is a disease characterized largely by the accumulation of out-of-control somatic mutations during the lifetime of a patient. Distinguishing driver mutations from passenger mutations has posed a challenge in modern cancer research. With the advanced development of microarray experiments and clinical studies, a large numbers of candidate cancer genes have been extracted and distinguishing informative genes out of them is essential. As a matter of fact, we proposed to find the informative genes for cancer by using mutation data from ovarian cancers in our framework. In our model we utilized the patient gene mutation profile, gene expression data and gene gene interactions network to construct a graphical representation of genes and patients. Markov processes for mutation and patients are triggered separately. After this process, cancer genes are prioritized automatically by examining their scores at their stationary distributions in the eigenvector. Extensive experiments demonstrate that the integration of heterogeneous sources of information is essential in finding important cancer genes.
癌症是一种主要由患者一生中失控的体细胞突变积累所特征化的疾病。区分驱动突变和乘客突变在现代癌症研究中构成了一项挑战。随着微阵列实验和临床研究的不断发展,大量候选癌症基因已被提取出来,从这些基因中区分出信息丰富的基因至关重要。事实上,我们提议在我们的框架中利用卵巢癌的突变数据来寻找癌症的信息丰富基因。在我们的模型中,我们利用患者基因突变谱、基因表达数据和基因-基因相互作用网络来构建基因和患者的图形表示。分别触发突变和患者的马尔可夫过程。在此过程之后,通过检查癌症基因在特征向量中平稳分布时的得分来自动对其进行优先级排序。大量实验表明,整合异质信息源对于找到重要的癌症基因至关重要。